Jimmy Lin is developing technologies to catch cancer months to years before current methods. He shares a breakthrough technique that looks for small signals of cancer's presence via a simple blood test, detecting the recurrence of some forms of the disease 100 days earlier than traditional methods. It could be a ray of hope in a fight where earl...

C. Jimmy Lin, MD, PhD, MHS is the Chief Scientific Officer (CSO), Oncology at Natera and a TED Fellow. He comes from a long history as a pioneer in cancer genomics. Most recently, he led the clinical genomics program at the National Cancer Institute (NCI) at the National Institutes of Health (NIH). Previously, at Johns Hopkins and Washington Uni...

Despite popular belief, winning the war on cancer is not more and better drugs. Chemotherapies are still front line in many cancers and cause horrible side effects. Despite advances in targeted therapies and immunotherapy, patients often treated too late and develop resistance. What we need to do is rethink our strategy. We need to move beyo...